Collection Periodical Articles [327/330] Books/Book Section [1/1] Conference Papers/Meeting Abstract [115/179] Siblings Winston C.Y. Yu [19/19] Ko-Jiunn Liu [85/98] Tsang-Wu Liu [119/125] Jieh-Yuan Liou(2003-2010) [3/3] Her-Shyong Shiah(1996-2012) [26/31] Shine-Gwo Shiah [51/54] Nai-Jung Chiang [82/94] Hui-Ju Mandy Ch'ang [39/44] Jang-Yang Chang [234/254] Kwang-Yu Chang [69/79] I-Shou Chang [103/106] Wun-Shaing Wayne Chang [52/53] Jeffrey Shu-Ming [89/91] Jacqueline Whang-Peng(1996-2007) [120/126] Neng-Yao Shih [37/43] Chia-Huei Lee [29/29] Alan Yueh-Luen Lee [48/49] Su-Fang Lin [32/32] Yi-Hsin Yang [41/42] Shih-Sheng Jiang [88/90] Che-Hung Shen [14/16] Wen-Chun Hung [88/88] Shuang-En Chuang [82/91] Kelvin Kun-Chih Tsai [32/34] Hui-Jen Tsai [66/71] Yung-Yeh Su [40/40] Jen-Liang Su [24/25] Ching-Chuan Kuo [71/76] Shang-Hung Chen [45/48] Jen-Yang Chen [72/72] Mei-Shya Chen(2002-2009) [1/1] Shih-Cheng Chen [2/2] Ya-Wen Chen [38/39] Tze-Sing Huang [55/55] Dau-Yang Huang [26/26] Chou-Chik George Ting(2000-2004) [5/5] Others [464/471] Ming Jacqueline Liu(1996-2007) [60/62] Mei-Ying Liu(2004-2006) [2/2] Cheng-Wen Wu(1996-2008) [53/55] Szu-Wen Tseng(1997-2007) [4/4] Kuan-Te Li(1997-2004) [4/6] Ching-Tai Lin(1999-2007) [5/5] Wen-Kuang Yang(1996-1999) [21/21] Chuan-Cheng Wang(1996-2003) [4/4] Shin-Hun P. Juang(1997-2004) [11/11] Tzung-Huang Jan(2000-2008) [2/2] Gi-Ming Lai(2004-2008) [41/47] Li-Jung Juan(2000-2006) [6/7] Jim-Ray Chen(2003-2007) [6/6] Yen-Ying Ma(1997-1999) [1/1] Chi-Ying F. Huang(2005-2007) [9/10] Community Statistics Item counts issued in 3 years:74(14.51%) Items With Fulltext:443(86.86%) Download counts of the item Download times greater than 0:443(100.00%) Download times greater than 100:426(96.16%) Total Bitstream Download Counts:178127(3.32%) Last Update: 2024-12-01 08:26 Top Upload Loading... Top Download Loading... Recent Submissions Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati... Survival of advanced/recurrent gast... Topiramate suppresses peri-infarct ... A phase 1 study of biweekly nab-pac... Plain language summary of the FOENI... Outcomes of post-immunotherapy dura... Durvalumab or placebo plus gemcitab... Impact of previous S-1 treatment on... Chromatin remodeling-related PRDM1 ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 151-175 of 510. (21 Page(s) Totally) << < 2 3 4 5 6 7 8 9 10 11 > >> View [10|25|50] records per page

Date	Title	Relation
2019-04-08	Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes	BMC Cancer. 2019 Apr 8;19:Article number 337.
2019-03	A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens	Gastric Cancer. 2019 Mar;22(2):344-354.
2019-03	Foreword	Hepatobiliary Surgery and Nutrition. 2019 Mar;8(Suppl. 1):S1.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling	Oncogene. 2019 Feb;38(8):1340-1353.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.]	Oncogene. 2019 Feb;38(8):1354.
2019-02	Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (attraction-4)	Annals of Oncology. 2019 Feb;30(2):250-258.
2019-02	NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors	European Journal of Cancer. 2019 Feb;108:78-87.
2019-02	Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 269.
2019-02	A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naive, advanced, or metastatic biliary tract cancer (BTC)	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 319.
2019-02	Evaluation of efficacy of nivolumab by baseline factors from ATTRACTION-2	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 8.
2019-02	A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements	Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number TPS468.
2019-01	Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin	European Journal of Cancer. 2019 Jan;106:24-33.
2019-01	Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS	Annals of Oncology. 2019 Jan;30(1):19-33.
2019-01	Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS	Annals of Oncology. 2019 Jan;30(1):34-43.
2019-01	Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer	Theranostics. 2019 Jan;9(2):324-336.
2018-12-20	Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression	Cancers. 2018 Dec 20;11(1):Article number 8.
2018-12	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2018 Dec;109(Suppl. 2):866.
2018-12	The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan	Cancer Science. 2018 Dec;109(Suppl. 2):1437.
2018-12	FOXO3a-driven alternation of metabolism dictates the gemcitabine sensitivity	Cancer Science. 2018 Dec;109(Suppl. 2):871.
2018-11-13	From friend to enemy: Dissecting the functional alteration of immunoregulatory components during pancreatic tumorigenesis	International Journal of Molecular Sciences. 2018 Nov 13;19(11):Article number 3584.
2018-11-07	Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial	European Journal of Cancer. 2018 Nov 7;105:71-78.
2018-11	The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan	Cancer Medicine. 2018 Nov;7(11):5775-5788.
2018-11	TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	Annals of Oncology. 2018 Nov;29(Suppl. 9):50.
2018-11	Liposomal irinotecan (nal-IRI) plus 5-FU/LV in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) progressing on gemcitabine-based treatment: Further subgroup analyses of the pivotal NAPOLI-1 study	Annals of Oncology. 2018 Nov;29(Suppl. 9):Meeting Abstract 200P.
2018-11	M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor beta (TGF-beta) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype	Annals of Oncology. 2018 Nov;29(Suppl. 9):Meeting Abstract 153O.

Showing items 151-175 of 510. (21 Page(s) Totally) << < 2 3 4 5 6 7 8 9 10 11 > >> View [10|25|50] records per page